EpiFix has demonstrated in previous studies very high rates of healing, with the original study showing 90%+ rates of healing in DFU wounds and 71% in VLU wounds.

With studies looking at long term follow up and the overall time to closure using weekly applications v biweekly, MiMedx demonstrates the effectiveness of EpiFix in hard to heal/non-healing ulcers.

The latest study further demonstrates this in a wider group of patients across multiple centres:

MiMedx Clinical Evidence Review

New Multicentre DFU RCT